swainsonine has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhay, ES; Bastos, LG; de-Freitas-Junior, JC; Freire-Neto, CA; Morgado-Díaz, JA; Rocher, BD | 1 |
| Deguchi, K; Hamaguchi, J; Kamiyama, N; Kudo, T; Nakagawa, H; Nishimura, S; Oshima, T; Sato, Y; Sun, B; Takahashi, M; Todo, S | 1 |
2 other study(ies) available for swainsonine and Colorectal Cancer
| Article | Year |
|---|---|
N-glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells.
Topics: Blotting, Western; Caco-2 Cells; Camptothecin; Cell Movement; Cell Survival; Cisplatin; Colorectal Neoplasms; Flow Cytometry; HCT116 Cells; HT29 Cells; Humans; Irinotecan; Polysaccharides; Swainsonine; Tunicamycin | 2012 |
Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines.
Topics: Animals; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Tolerance; Fluorouracil; Gene Expression Regulation, Neoplastic; Mice; Polysaccharides; RNA, Messenger; Swainsonine | 2007 |